Why the study?
Do antihypertensive regimens including ACE inhibitors reduce the progression to end-stage renal disease in patients with nondiabetic renal disease?
Population
1,860 nondiabetic patients with predominantly nondiabetic renal disease pooled from 11 randomized…
Comparison
Antihypertensive regimens including ACE inhibitors vs Antihypertensive regimens without ACE inhibitors
Design
Meta-analysis
Follow-up
mean 2.2 years
Authors
Loading...
Supports ACE inhibitor regimens in nondiabetic CKD; confirms renal protection in Level 1 meta-analysis.
Do antihypertensive regimens including ACE inhibitors reduce the progression to end-stage renal disease in patients with nondiabetic renal disease?
Antihypertensive regimens containing ACE inhibitors significantly slow the progression of nondiabetic renal disease, with greater benefits observed in patients with higher baseline proteinuria.
Tazeen H. Jafar (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: